Mesothelin Chimeric Antigen Receptor (CAR)-Mediated Therapy for Ovarian Cancer

Oksana V. Gruzdyn; Scott A. Gruber; Ramesh B. Batchu; Ebrahem M. Mahmud; Fatme K. Chukr; Rajesh Dachepalli; Santosh K. Manmari; Advaitha Tiruvaipati; Gamal Mostafa; Donald W. Weaver

doi:10.1016/j.jamcollsurg.2017.07.645

Back

Mesothelin Chimeric Antigen Receptor (CAR)-Mediated Therapy for Ovarian Cancer

Journal article

Peer reviewed

Mesothelin Chimeric Antigen Receptor (CAR)-Mediated Therapy for Ovarian Cancer

Oksana V. Gruzdyn, Scott A. Gruber, Ramesh B. Batchu, Ebrahem M. Mahmud, Fatme K. Chukr, Rajesh Dachepalli, Santosh K. Manmari, Advaitha Tiruvaipati, Gamal Mostafa and Donald W. Weaver

Journal of the American College of Surgeons, Vol.225(4), pp.e47-e47

10/2017

DOI: https://doi.org/10.1016/j.jamcollsurg.2017.07.645

Metrics

1 Record Views

Details

Title: Mesothelin Chimeric Antigen Receptor (CAR)-Mediated Therapy for Ovarian Cancer
Creators - without role: Oksana V. Gruzdyn - John D. Dingell VA Medical Center
Scott A. Gruber - Wayne State University
Ramesh B. Batchu - John D. Dingell VA Medical Center
Ebrahem M. Mahmud - Wayne State University
Fatme K. Chukr - Wayne State University
Rajesh Dachepalli - John D. Dingell VA Medical Center
Santosh K. Manmari - Wayne State University
Advaitha Tiruvaipati - John D. Dingell VA Medical Center
Gamal Mostafa - John D. Dingell VA Medical Center
Donald W. Weaver - John D. Dingell VA Medical Center
Publication Details: Journal of the American College of Surgeons, Vol.225(4), pp.e47-e47
Identifiers: 9953188008331
Academic Unit: King Saud University
Language: English
Resource Type: Journal article